Abstract:Background: IL-17 plays a pathogenic role in asthma. ST2(-) inflammatory group 2 innate lymphoid cells (ILC2s) driven by IL-25 can produce IL-17, whereas ST2(+) natural ILC2s produce little IL-17. Objective: We characterized ST2(+) IL-17(+) ILC2s during lung inflammation and determined the pathogenesis and molecular regulation of ST2(+)IL-17(+) ILC2s. Methods: Lung inflammation was induced by papain or IL-33. IL-17 production by lung ILC2s from wild-type, Rag1(-/-), Rorc(gfp/gfp), and aryl hydrocarbon receptor (Ahr)(-/-) mice was examined by using flow cytometry. Bone marrow transfer experiments were performed to evaluate hematopoietic myeloid differentiation primary response gene-88 (MyD88) signaling in regulating IL-17 production by ILC2s. mRNA expression of IL-17 was analyzed in purified naive ILC2s treated with IL-33, leukotrienes, and inhibitors for nuclear factor of activated T cells, p38, c-Jun N-terminal kinase, or nuclear factor kappa light-chain enhancer of activated B cells. The pathogenesis of IL-17(+) ILC2s was determined by transferring wild-type or Il17(-/-) ILC2s to Rag2(-/-) Il2rg(-/-) mice, which further induced lung inflammation. Finally, expression of 106 ILC2 signature genes was compared between ST2(+)IL-17(+) ILC2s and ST2(+)IL-17(-) ILC2s. Results: Papain or IL-33 treatment boosted IL-17 production from ST2(+) ILC2s (referred to by us as ILC2(17)s) but not ST2(-) ILC2s. Ahr, but not retinoic acid receptor-related orphan receptor gamma t, facilitated the production of IL-17 by ILC2(17)s. The hematopoietic compartment of MyD88 signaling is essential for ILC2(17) induction. IL-33 works in synergy with leukotrienes, which signal through nuclear factor of activated T-cell activation to promote IL-17 in ILC2(17)s. Il17(-/-) ILC2s were less pathogenic in lung inflammation. ILC2(17)s concomitantly expressed IL-5 and IL-13 but expressed little GM-CSF. Conclusion: During lung inflammation, IL-33 and leukotrienes synergistically induce ILC2(17)s. ILC2(17)s are a highly pathogenic and unexpected source for IL-17 in lung inflammation.

Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lung

The Origin and Role of Innate Lymphoid Cells in the Lung

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

Identification of Group 2 Innate Lymphoid Cells in Mouse Lung, Liver, Small Intestine, Bone Marrow, and Mediastinal and Mesenteric Lymph Nodes

Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis

Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation

IL-17–producing ST2+ Group 2 Innate Lymphoid Cells Play a Pathogenic Role in Lung Inflammation

Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells

LTi-like type 3 innate lymphoid cells are associated with the transient induction of tertiary lymphoid structures in inflamed pulmonary tissue

Cis-acting Lnc-Cxcl2 Restrains Neutrophil-Mediated Lung Inflammation by Inhibiting Epithelial Cell CXCL2 Expression in Virus Infection

Innate lymphoid cells — how did we miss them?

Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity

Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells.

Allergic Inflammation is Exacerbated by Allergen-Induced Type 2 Innate Lymphoid Cells in a Murine Model of Allergic Rhinitis.

Cross-talk between ILC2 and Gata3 high T regs locally constrains adaptive type 2 immunity

Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans

Differential Role of Id2 in the Group 3 Innate Lymphoid Cells for the Development of Different Gut Associated Lymphoid Tissues

Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells

Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness

Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses

Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity